Navigation Links
VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R)
Date:5/14/2009

ATLANTA, May 14 /PRNewswire/ -- ANY LAB TEST NOW(R), the first retail direct-access lab testing franchise with over 55 locations nationwide, has partnered with Atherotech, Inc., a Birmingham, Alabama-based CLIA-laboratory to provide the VAP(R) Cholesterol Test direct to consumers at an affordable price. The VAP Cholesterol Test is an expanded cholesterol profile that identifies a greater number of people at risk and is the first cholesterol test to directly measure LDL.

ANY LAB TEST NOW continues to revolutionize direct-access lab testing by offering thousands of medical lab tests and Value Panels affordably to consumers and businesses in a convenient retail setting. Each location works with local physicians to provide patients -- specifically self-pay and un-/under-insured -- with a more affordable lab testing alternative. No appointment or insurance is necessary and results are typically given within 24-48 hours.

The comprehensive VAP Cholesterol Test is based on ultracentrifugation, the "gold standard" method of measuring cholesterol. Through this process, the VAP Test gives customers and their doctors comprehensive information on the treatment and management of cardiovascular conditions. The test, which doesn't require fasting, provides direct measurements of LDL, HDL and all relevant subclasses, and includes non-HDL, a highly accurate determination of apoB, and emerging risk factors such as Lp(a), remnants and small dense LDL.

"We are excited to bring the VAP Test directly to consumers at such an attractive price point because it empowers them to manage their own health, gain more insight in their cardiovascular health and provide their health care provider with more information to accurately treat and manage their health," said Joe Neely, chief executive officer of ANY LAB TEST NOW.

"ANY LAB TEST NOW is a good fit for the VAP Test as it allows a growing population more access at an af
'/>"/>

SOURCE ANY LAB TEST NOW; Atherotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Atherotech to Exhibit its VAP(R) Cholesterol Test at Internal Medicine 2009 in Philadelphia
2. Atherotech to Exhibit the VAP(R) Cholesterol Test at ACC.09 in Orlando
3. Atherotech Announces Addition of ApoAI Heart Disease, Diabetes Risk Marker to VAP(R) Test
4. VAP(R) Cholesterol Test Helps Researchers Identify Treatment Effects of Combination Therapy
5. Atherotech to Exhibit VAP(R) Cholesterol Test at American Heart Association Scientific Sessions 2008
6. VAP(R) Cholesterol Test From Atherotech Covers an Additional 9 Million of Florida Insured
7. VAP(R) Cholesterol Test Bolsters Biophysical(R) Health Assessment
8. First Application to Fight High Cholesterol Launches on the iPhone and iPod Touch
9. VAP Cholesterol Test Helps In Search For New Heart Disease Drugs
10. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
11. New Data Published in Circulation Showed an Increase in HDL Cholesterol Levels with ACTOS(R) (pioglitazone HCl)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Dr. Kerry Solomon announ... and has launched his redesigned website at www.D... Consulting Group. Dr. Solomon is a proven LASIK,... been professionally recognized for his substantia...gery. He is a member of Trusted LASIK Surgeons, w...
(Date:12/1/2009)..., , PLYMOUTH, Mass., Dec. 1 /PRNewswire/ -... ) announced today results from the company sponso...achandra Medical Center in Chennai, India using th...-reconstructable Critical Limb Ischemia (CLI). Sri...nternational-associated institution based in Chenn...
(Date:12/1/2009)..., , SPRINGFIELD, Ill., Dec. 1 /PRNewswi... is proud to announce that it was recently awarded...Awards event on Nov. 13 in New York City. The CLIO...and innovation in the healthcare advertising indus... the world,s most recognized awards competitions f...
(Date:12/1/2009)..., , CRANBURY, N.J., Dec. 1 /PRNewswire-Fir... PTN ) today announced that the U.S. Patent and Tr...0, titled "Cyclic Natriuretic Peptide Constructs."...f cyclic compounds that bind to natriuretic peptid...lead heart failure drug candidate. ,, "Our natr...
Breaking Biology Technology:Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3
...tal Joins Flagship Ventures Backing Leader in Fluo...ng--, WOBURN, Mass., Oct. 23 VisEn Medical, Inc....search through medicine, today,announced the compl...tures,joined Flagship Ventures to co-lead this $7 ...Bollard Group and other existing investors. Per Lo...
...ring the first hypoallergenic kittens to customers...blished a unique place in the pet ...23 ALLERCA, the company that,developed the first ...rating the one year anniversary of the first kitte...ompany has delivered dozens of the,ALLERCA ,sneeze...
...s., Oct. 23 Arbios Systems, Inc.,(OTC: ABOS) toda...manufacturing agreement with NxStage Medical, Inc....iver Assist Device developed by Arbios for use,in ...g permission from the,US Food and Drug Administrat...or SEPET(TM). Under the terms of the agreement, N...
Other Biology Technology:VisEn Medical Raises $7 Million in Series B Financing 2VisEn Medical Raises $7 Million in Series B Financing 3One Year On, ALLERCA Hypoallergenic Cats Bring 'Sneeze Free' Companionship to Allergy and Asthma Sufferers 2One Year On, ALLERCA Hypoallergenic Cats Bring 'Sneeze Free' Companionship to Allergy and Asthma Sufferers 3Arbios Announces SEPET(TM) Manufacturing Agreement With NxStage Medical 2Arbios Announces SEPET(TM) Manufacturing Agreement With NxStage Medical 3Arbios Announces SEPET(TM) Manufacturing Agreement With NxStage Medical 4
(Date:11/30/2009)...omprehensive review of the state of Antarctica,s c...system is published this week (Tuesday 1 December)... (SCAR). The review - Antarctic Climate Change an...om the icy continent, identifies areas for future ...tions that policy makers have about Antarctic melt...
(Date:11/30/2009)...Clemson University researchers Ron Falta and Larry...rotection Agency grant to study the safe storage o...deep below the earth,s surface. , With carbon di... to be the leading cause of global warming, geolog... alternatives for reducing emissions using current...
(Date:11/30/2009)... University of Pittsburgh team overcame a major hu...h as those that could lead to more efficient catal...st less toxic. The researchers reported Nov. 29 in...h-temperature stability in metallic nanoparticles,... a vulnerability to extreme heat. , Gtz Veser, a...
Breaking Biology News(10 mins):First comprehensive review of the state of Antarctica's climate 2First metallic nanoparticles resistant to extreme heat 2Gamida Cell and Cellerix Partner on Feasibility Study 14558 1Gamida Cell and Cellerix Partner on Feasibility Study 14558 2Gamida Cell and Cellerix Partner on Feasibility Study 14558 3Delcath Systems Inc Completes Phase III Study Enrollment 5635 1Delcath Systems Inc Completes Phase III Study Enrollment 5635 2Delcath Systems Inc Completes Phase III Study Enrollment 5635 3NASCSA Receives 24200 000 Grant From Purdue Pharma L P to Support State Prescription Drug Monitoring Programs 5633 1NASCSA Receives 24200 000 Grant From Purdue Pharma L P to Support State Prescription Drug Monitoring Programs 5633 2
...e thousands of proteins produced in our cells, few...AP), which has the unique ability to faithfully co...nisms--from bacteria to people--depend on RNAP to ... Despite its crucial role in cell biology, fundame...tually works. , Now scientists from Stanford Univ...
...imates evolved 7 million years ago, the more advan...ty of Central Florida researchers believe can effe...fecting blood cells. , HIV-1 often mutates quickl...ent infections. But a research team led by Associa...ge of Biomedical Sciences has demonstrated that ov...
... Hopkins scientists have found that a method they ...of cells and some of their genetic blueprint is tw... a pathologist,s view with a microscope. , The s...o Fackler, Ph.D., first separates cells from fluid...ags on certain genes associated with cancer. , R...
Other Biology News:When it comes to gene transcription, random pauses aren’t quite so random, study finds 2When it comes to gene transcription, random pauses aren’t quite so random, study finds 3When it comes to gene transcription, random pauses aren’t quite so random, study finds 4Defense peptide found in primates may block some human HIV transmissions 2Defense peptide found in primates may block some human HIV transmissions 3Gene screen for breast cancer better than pathologist's 'eye' 2
Rabbit Anti-pCrosstide Polyclonal Antibody, Horseradish Peroxidase Conjugated from Abcam
Anti-Histone H2B, acetyl (Lys20) Antibody, Unconjugated from Cell Signaling Technology
Congo Red Solution from ScyTek Laboratories
Rabbit Anti-ATGL Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Biology Products: